Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

HC Wainwright & Co. Maintains Buy Rating for Atara Biotherapeutics: Here's What You Need To Know

HC Wainwright & Co. has decided to maintain its Buy rating of Atara Biotherapeutics (NASDAQ:ATRA) and lower its price target from $31.00 to $29.00. Shares of Atara Biotherapeutics are trading down 3.1% over the last 24 hours, at $5.00 per share.

Benzinga

Here's How Much You Would Have Made Owning Alphabet Stock In The Last 15 Years

Alphabet (NASDAQ:GOOGL) has outperformed the market over the past 15 years by 9.3% on an annualized basis producing an average annual return of 15.88%. Currently, Alphabet has a market capitalization of $1.46 trillion.

Benzinga

Analyst Ratings for Varonis Systems

Varonis Systems (NASDAQ:VRNS) has observed the following analyst ratings within the last quarter:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Outlook For Ituran Location & Control

Ituran Location & Control (NASDAQ:ITRN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement.

Benzinga

Earnings Preview For 360 Finance

360 Finance (NASDAQ:QFIN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that 360 Finance will report an earnings per share (EPS) of $1.08.

Benzinga

MindMed Appoints Schond L. Greenway As CFO

Mind Medicine Inc. (NASDAQ: MNMD), (NEO:MMED), a clinical stage bio-pharmaceutical company developing novel products to treat brain health disorders, appointed Schond L. Greenway as CFO.

Benzinga

Earnings Outlook For Arco Platform

Arco Platform (NASDAQ:ARCE) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Arco Platform will report an earnings per share (EPS) of $0.13.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

4 Analysts Have This to Say About Jounce Therapeutics

Jounce Therapeutics (NASDAQ:JNCE) has observed the following analyst ratings within the last quarter:

Benzinga

Here's How Much You Would Have Made Owning Advanced Micro Devices Stock In The Last 20 Years

Advanced Micro Devices (NASDAQ:AMD) has outperformed the market over the past 20 years by 4.25% on an annualized basis producing an average annual return of 10.99%. Currently, Advanced Micro Devices has a market capitalization of $148.42 billion.

Benzinga

Here's How Much $100 Invested In Microsoft 20 Years Ago Would Be Worth Today

Microsoft (NASDAQ:MSFT) has outperformed the market over the past 20 years by 5.35% on an annualized basis producing an average annual return of 12.09%. Currently, Microsoft has a market capitalization of $1.93 trillion.

Benzinga

Arcimoto To Provide Electric Wine Country Tours In Temecula Valley

Arcimoto Inc (NASDAQ:FUV) has partnered with Cable Car Wine Tours to provide all-electric wine country tours in Temecula Valley, California. Through this arrangement, visitors will be able to explore Southern California's Wine Country in fleets of Fun Utility Vehicles in both guided and self-guided tours. "As residents of the Willamette Valley here in…

Benzinga

Krispy Kreme's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Krispy Kreme (NASDAQ:DNUT).

Benzinga

Jack Henry & Associates: Dividend Insights

Wednesday marks the last chance for investors to receive the next dividend payout from Jack Henry & Associates (NASDAQ:JKHY).

Benzinga

Marriott To Debut This Private Sanctuary As Part Of Saudi Arabia's Red Sea Destination

Marriott International Inc (NASDAQ:MAR) has signed an agreement with The Red Sea Development Company to debut its Ritz-Carlton Reserve brand off the west coast of Saudi Arabia. Slated to debut in 2023, Nujuma, a Ritz-Carlton Reserve, will be the first property from the brand in the Middle East. Nujuma will be situated on private islands…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Wednesday Is Your Last Chance To Buy National Research Before The Dividend Payout

Wednesday marks the last chance for investors to receive the next dividend payout from National Research (NASDAQ:NRC).

Benzinga

What Are Whales Doing With Costco Wholesale

Someone with a lot of money to spend has taken a bearish stance on Costco Wholesale (NASDAQ:COST). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Expert Ratings for Frontdoor

Frontdoor (NASDAQ:FTDR) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Preview For Petco Health and Wellness

Petco Health and Wellness (NASDAQ:WOOF) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Petco Health and Wellness will report an earnings per share (EPS) of $0.16.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Analyst Ratings for Amgen

Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter:

Benzinga

Analyst Ratings for Bicycle Therapeutics

Bicycle Therapeutics (NASDAQ:BCYC) has observed the following analyst ratings within the last quarter:

Benzinga

NMI Holdings's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, NMI Holdings (NASDAQ:NMIH) earned $67.68 million, a 11.82% increase from the preceding quarter. NMI Holdings also posted a total of $127.44 million in sales, a 1.89% increase since Q4.

Benzinga

Inari Medical's Return On Capital Employed Insights

Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter.

Benzinga

PetIQ's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, PetIQ (NASDAQ:PETQ) earned $3.16 million, a 121.83% increase from the preceding quarter. PetIQ also posted a total of $275.69 million in sales, a 40.21% increase since Q4.

Benzinga

Looking Into Open Text's Return On Capital Employed

Pulled from Benzinga Pro data, Open Text (NASDAQ:OTEX) showed a loss in earnings since Q2, totaling $74.72 million. Sales, on the other hand, increased by 0.63% to $882.28 million during Q3.

Benzinga

Heritage-Crystal Clean's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Heritage-Crystal Clean (NASDAQ:HCCI) posted Q1 earnings of $12.88 million, an increase from Q4 of 28.94%. Sales dropped to $139.37 million, a 17.78% decrease between quarters.

1 … 479 480 481 482

Organisations

Advanced Micro Devices

Marriott International Inc

14 stories

Petco Health and Wellness

13 stories

Varonis Systems

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.